We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Xylem (XYL) Up 1.2% Since Last Earnings Report: Can It Continue?
Read MoreHide Full Article
A month has gone by since the last earnings report for Xylem (XYL - Free Report) . Shares have added about 1.2% in that time frame, outperforming the S&P 500.
Will the recent positive trend continue leading up to its next earnings release, or is Xylem due for a pullback? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at its most recent earnings report in order to get a better handle on the important drivers.
Xylem Beats on Q1 Earnings, Increases '21 Projections
Xylem has delivered impressive results for first-quarter 2021. Its earnings surpassed the Zacks Consensus Estimate by 51.4%. Also, quarterly sales exceeded estimates by 7.1%.
Adjusted earnings in the quarter under review were 56 cents per share, surpassing the Zacks Consensus Estimate of 69 cents. Also, the bottom line increased 143.5% from the year-ago figure of 23 cents on the back of higher sales generation and margin improvement.
It is worth noting that movements in foreign currencies had a positive impact of 4 cents per share on earnings.
Revenue Details
In the quarter under review, Xylem’s revenues were $1,256 million, reflecting an 11.8% increase from the year-ago quarter. Organic sales in the quarter increased 8% on the back of healthy demand in the three segments.
Also, the company’s revenues surpassed the Zacks Consensus Estimate of $1,173 million.
Orders in the reported quarter increased 22% year over year to $1,538 million. Organically, orders grew 19% or expanded 18% on a constant-currency basis.
The company reports net sales under three segments, which are Water Infrastructure, Applied Water, and Measurement & Control Solutions. The segmental information is briefly discussed below:
Revenues in the Water Infrastructure segment were $509 million, up 16.2% year over year. Organic sales in the quarter grew 11% year over year. Businesses in both industrial and utilities end markets flourished in the quarter.
The Applied Water segment generated revenues of $393 million in the first quarter, up 16.3% year over year. Organic sales increased 13% on a year-over-year basis. Businesses in commercial, industrial and residential markets were healthy.
Quarterly revenues of the Measurement & Control Solutions segment were $354 million, up 2% year over year. Organic sales were flat year over year or down 1% on a constant-currency basis. Benefits from water application demand in the test business were offset by weakness caused by setbacks in deployments of smart metrology.
Margin Profile
In first-quarter 2021, Xylem’s cost of sales increased 7.3% year over year to $766 million. As a percentage of revenues, it represented 61% versus 63.6% in the year-ago quarter. Selling, general and administrative expenses increased 19.8% to $490 million. Meanwhile, research and development expenses grew 1.3% to $301 million.
In the reported quarter, the company’s adjusted EBITDA were $215 million, increasing 55.8% from the year-ago quarter. Margin in the quarter grew 480 basis points (bps) year over year to 17.1%. Productivity gains, healthy demand and costs actions aided the results.
Adjusted operating income was $143 million in the quarter under review, up 104.3% year over year. Operating margin grew 520 bps to 11.4%. Interest expenses in the reported quarter totaled $21 million, up from $16 million in the year-ago quarter.
Balance Sheet and Cash Flow
Exiting the first quarter of 2021, Xylem had cash and cash equivalents of $1,688 million, decreasing 10% from $1,875 million at the end of the last reported quarter. Long-term debt balance decreased 1% sequentially to $2,460 million.
In the reported quarter, the company used cash of $26 million for operating activities as compared with $2 million cash utilized in the year-ago quarter. Capital expenditure was $39 million, down 23.5% from the year-ago figure of $51 million.
Shareholder-Friendly Policies
In first-quarter 2021, the company paid out dividends of $51 million, reflecting an increase of 6.3% from the year-ago quarter. Share repurchased amounted to $67 million, up 11.7% year over year.
Outlook
For 2021, Xylem increased its organic revenue growth projection to 5-7% from the previously stated 3-5%. Total revenues are predicted to increase 8-10% as compared with 6-8% mentioned previously.
Adjusted earnings per share in the year are anticipated to be $2.50-$2.710, higher than $2.35-$2.60 mentioned previously. The improvement mirrors improvement in demand and commercial activities.
How Have Estimates Been Moving Since Then?
In the past month, investors have witnessed an upward trend in estimates revision. The consensus estimate has shifted 5.38% due to these changes.
VGM Scores
Currently, Xylem has an average Growth Score of C, however its Momentum Score is doing a bit better with a B. However, the stock was allocated a grade of F on the value side, putting it in the bottom 20% quintile for this investment strategy.
Overall, the stock has an aggregate VGM Score of D. If you aren't focused on one strategy, this score is the one you should be interested in.
Outlook
Estimates have been trending upward for the stock, and the magnitude of these revisions looks promising. It comes with little surprise Xylem has a Zacks Rank #2 (Buy). We expect an above average return from the stock in the next few months.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Xylem (XYL) Up 1.2% Since Last Earnings Report: Can It Continue?
A month has gone by since the last earnings report for Xylem (XYL - Free Report) . Shares have added about 1.2% in that time frame, outperforming the S&P 500.
Will the recent positive trend continue leading up to its next earnings release, or is Xylem due for a pullback? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at its most recent earnings report in order to get a better handle on the important drivers.
Xylem Beats on Q1 Earnings, Increases '21 Projections
Xylem has delivered impressive results for first-quarter 2021. Its earnings surpassed the Zacks Consensus Estimate by 51.4%. Also, quarterly sales exceeded estimates by 7.1%.
Adjusted earnings in the quarter under review were 56 cents per share, surpassing the Zacks Consensus Estimate of 69 cents. Also, the bottom line increased 143.5% from the year-ago figure of 23 cents on the back of higher sales generation and margin improvement.
It is worth noting that movements in foreign currencies had a positive impact of 4 cents per share on earnings.
Revenue Details
In the quarter under review, Xylem’s revenues were $1,256 million, reflecting an 11.8% increase from the year-ago quarter. Organic sales in the quarter increased 8% on the back of healthy demand in the three segments.
Also, the company’s revenues surpassed the Zacks Consensus Estimate of $1,173 million.
Orders in the reported quarter increased 22% year over year to $1,538 million. Organically, orders grew 19% or expanded 18% on a constant-currency basis.
The company reports net sales under three segments, which are Water Infrastructure, Applied Water, and Measurement & Control Solutions. The segmental information is briefly discussed below:
Revenues in the Water Infrastructure segment were $509 million, up 16.2% year over year. Organic sales in the quarter grew 11% year over year. Businesses in both industrial and utilities end markets flourished in the quarter.
The Applied Water segment generated revenues of $393 million in the first quarter, up 16.3% year over year. Organic sales increased 13% on a year-over-year basis. Businesses in commercial, industrial and residential markets were healthy.
Quarterly revenues of the Measurement & Control Solutions segment were $354 million, up 2% year over year. Organic sales were flat year over year or down 1% on a constant-currency basis. Benefits from water application demand in the test business were offset by weakness caused by setbacks in deployments of smart metrology.
Margin Profile
In first-quarter 2021, Xylem’s cost of sales increased 7.3% year over year to $766 million. As a percentage of revenues, it represented 61% versus 63.6% in the year-ago quarter. Selling, general and administrative expenses increased 19.8% to $490 million. Meanwhile, research and development expenses grew 1.3% to $301 million.
In the reported quarter, the company’s adjusted EBITDA were $215 million, increasing 55.8% from the year-ago quarter. Margin in the quarter grew 480 basis points (bps) year over year to 17.1%. Productivity gains, healthy demand and costs actions aided the results.
Adjusted operating income was $143 million in the quarter under review, up 104.3% year over year. Operating margin grew 520 bps to 11.4%. Interest expenses in the reported quarter totaled $21 million, up from $16 million in the year-ago quarter.
Balance Sheet and Cash Flow
Exiting the first quarter of 2021, Xylem had cash and cash equivalents of $1,688 million, decreasing 10% from $1,875 million at the end of the last reported quarter. Long-term debt balance decreased 1% sequentially to $2,460 million.
In the reported quarter, the company used cash of $26 million for operating activities as compared with $2 million cash utilized in the year-ago quarter. Capital expenditure was $39 million, down 23.5% from the year-ago figure of $51 million.
Shareholder-Friendly Policies
In first-quarter 2021, the company paid out dividends of $51 million, reflecting an increase of 6.3% from the year-ago quarter. Share repurchased amounted to $67 million, up 11.7% year over year.
Outlook
For 2021, Xylem increased its organic revenue growth projection to 5-7% from the previously stated 3-5%. Total revenues are predicted to increase 8-10% as compared with 6-8% mentioned previously.
Adjusted earnings per share in the year are anticipated to be $2.50-$2.710, higher than $2.35-$2.60 mentioned previously. The improvement mirrors improvement in demand and commercial activities.
How Have Estimates Been Moving Since Then?
In the past month, investors have witnessed an upward trend in estimates revision. The consensus estimate has shifted 5.38% due to these changes.
VGM Scores
Currently, Xylem has an average Growth Score of C, however its Momentum Score is doing a bit better with a B. However, the stock was allocated a grade of F on the value side, putting it in the bottom 20% quintile for this investment strategy.
Overall, the stock has an aggregate VGM Score of D. If you aren't focused on one strategy, this score is the one you should be interested in.
Outlook
Estimates have been trending upward for the stock, and the magnitude of these revisions looks promising. It comes with little surprise Xylem has a Zacks Rank #2 (Buy). We expect an above average return from the stock in the next few months.